» Articles » PMID: 18053086

Pleomorphism of the Nuclear Envelope in Breast Cancer: a New Approach to an Old Problem

Overview
Journal J Cell Mol Med
Date 2007 Dec 7
PMID 18053086
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

In routine practice, nuclear pleomorphism of tumours is assessed by haematoxylin staining of the membrane-bound heterochromatin. However, decoration of the nuclear envelope (NE) through the immunofluorescence staining of NE proteins such as lamin B and emerin can provide a more objective appreciation of the nuclear shape. In breast cancer, nuclear pleomorphism is one of the least reproducible parameters to score histological grade, thus we sought to use NE proteins to improve the reproducibility of nuclear grading. First, immuno-fluorescence staining of NE as well as confocal microscopy and three-dimensional reconstruction of nuclei in cultured cells showed a smooth and uniform NE of normal breast epithelium in contrast to an irregular foldings of the membrane and the presence of deep invaginations leading to the formation of an intranuclear scaffold of NE-bound tubules in breast cancer cells. Following the above methods and criteria, we recorded the degree of NE pleomorphism (NEP) in a series of 273 invasive breast cancers tested by immunofluorescence. A uniform nuclear shape with few irregularities (low NEP) was observed in 135 cases or, alternatively, marked folds of the NE and an intranuclear tubular scaffold (high NEP cases) were observed in 138 cases. The latter features were significantly correlated (P-value <0.002) with lymph node metastases in 54 histological grade 1 and in 173 cancers with low mitotic count. Decoration of the NE might thus be regarded as a novel diagnostic parameter to define the grade of malignancy, which parallels and enhances that provided by routine histological procedures.

Citing Articles

Extreme wrinkling of the nuclear lamina is a morphological marker of cancer.

Wang T, Dollahon C, Mishra S, Patel H, Abolghasemzade S, Singh I NPJ Precis Oncol. 2024; 8(1):276.

PMID: 39623008 PMC: 11612457. DOI: 10.1038/s41698-024-00775-8.


Emerin deficiency drives MCF7 cells to an invasive phenotype.

Hansen E, Rolling C, Wang M, Holaska J Sci Rep. 2024; 14(1):19998.

PMID: 39198511 PMC: 11358522. DOI: 10.1038/s41598-024-70752-5.


Emerin deficiency drives MCF7 cells to an invasive phenotype.

Hansen E, Rolling C, Wang M, Holaska J bioRxiv. 2024; .

PMID: 38712242 PMC: 11071294. DOI: 10.1101/2024.02.21.581379.


Alzheimer's disease and related tauopathies: disorders of disrupted neuronal identity.

Frost B Trends Neurosci. 2023; 46(10):797-813.

PMID: 37591720 PMC: 10528597. DOI: 10.1016/j.tins.2023.07.006.


The nuclear envelope and metastasis.

Hansen E, Holaska J Oncotarget. 2023; 14:317-320.

PMID: 37057891 PMC: 10103595. DOI: 10.18632/oncotarget.28375.


References
1.
Fischer A, Bond J, Taysavang P, Battles O, Wynford-Thomas D . Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure. Am J Pathol. 1998; 153(5):1443-50. PMC: 1853418. DOI: 10.1016/S0002-9440(10)65731-8. View

2.
Morris G . The role of the nuclear envelope in Emery-Dreifuss muscular dystrophy. Trends Mol Med. 2001; 7(12):572-7. DOI: 10.1016/s1471-4914(01)02128-1. View

3.
Fischer A, Taysavang P, Jhiang S . Nuclear envelope irregularity is induced by RET/PTC during interphase. Am J Pathol. 2003; 163(3):1091-100. PMC: 1868259. DOI: 10.1016/S0002-9440(10)63468-2. View

4.
Baak J, van Diest P, Voorhorst F, van der Wall E, Beex L, Vermorken J . Prospective multicenter validation of the independent prognostic value of the mitotic activity index in lymph node-negative breast cancer patients younger than 55 years. J Clin Oncol. 2005; 23(25):5993-6001. DOI: 10.1200/JCO.2005.05.511. View

5.
Coradeghini R, Barboro P, Rubagotti A, Boccardo F, Parodi S, Carmignani G . Differential expression of nuclear lamins in normal and cancerous prostate tissues. Oncol Rep. 2006; 15(3):609-13. View